Jeffery Brinza was Promoted as Chief Administrative Officer and General Counsel at Millendo

Date of management change: June 28, 2018 

What Happened?

Ann Arbor, -based Millendo Promoted Jeffery Brinza as Chief Administrative Officer and General Counsel


About the Company

Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing`s Syndrome (CS).


About the Person

Jeffery Brinza is Chief Administrative Officer and General Counsel at Millendo. Previously, Jeffery held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Gromer Dennis, Westfall-McGrail Jennifer, Cross Jeffrey, Rotsztain Diego, Fredland Valita, Wong Yanira, McLean James, Haden Clay, Frantz Carolyn, George Sajju, Imbornone Angela

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.